Horn-Lohrens, O <br/><br/>
Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).  [electronic resource] 

 -  International journal of cancer  Feb 1995 
 - 539-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.2910600419  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--biosynthesis<br/>Antibodies, Neoplasm--biosynthesis<br/>Antibody Specificity<br/>Antigen-Antibody Reactions<br/>Binding, Competitive<br/>Epitopes<br/>Hodgkin Disease--immunology<br/>Ki-1 Antigen--biosynthesis<br/>Lymphocyte Activation<br/>Mice<br/>Mice, Inbred BALB C<br/>Solubility<br/>Tumor Cells, Cultured--immunology